title: Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer.
authors.affiliation: Adult Nephrology Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: Linda
authors.initials: L
authors.lastname: Shavit
authors.affiliation: Adult Nephrology Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: Meyer D
authors.initials: MD
authors.lastname: Lifschitz
authors.affiliation: Shaare Zedek Medical Center, Department of Oncology, Jerusalem, Israel.
authors.forename: Alberto
authors.initials: A
authors.lastname: Gabizon
authors.affiliation: NYU Langone Medical Center, New York, New York, USA.
authors.forename: Maryann
authors.initials: M
authors.lastname: Kwa
authors.affiliation: NYU Langone Medical Center, New York, New York, USA.
authors.forename: Franco
authors.initials: F
authors.lastname: Muggia
authors.affiliation: Adult Nephrology Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: Itzchak
authors.initials: I
authors.lastname: Slotki
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005921:Glomerulonephritis / Q000209:etiology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007678:Kidney Glomerulus / Q000187:drug effects*; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*; D010257:Paraneoplastic Syndromes / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents